Login / Signup

Anti-proliferative activity of RIHMS-Qi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinases.

Randa El-GamalSara ElfarrashMohammad El-NablawayAsmaa Ahmed SalemSeyed-Omar ZaraeiHanan S AnbarAshraf ShomaMohammed I El-Gamal
Published in: BMC cancer (2023)
RIMHS-Qi-23 is exerting an anti-proliferative effect that is more potent and selective than doxorubicin.
Keyphrases
  • cell proliferation
  • cancer therapy
  • drug delivery
  • dna damage
  • endothelial cells
  • breast cancer cells
  • anti inflammatory
  • pi k akt
  • oxidative stress